RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Ruthigen, Pulmatrix Shareholders Approve Merger
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.